Amarin Corporation Plc Profile, SWOT Analysis and Company Tech Intelligence Report 2018

Report Name: Amarin Corporation Plc Profile – Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

Amarin Corporation Plc Report – Publisher: Research Cosmos

Price Scheme of the Report:

Single User License – USD 150

Team License – USD 175

Corporate License – USD 250

Amarin Corporation Plc – Business Description:

Amarin Corporation Plc is engaged in the research and development, and manufacturing of drugs for the cardiovascular diseases. The company operates in Ireland, Scotland, the US and Israel. The company is engaged in the development of Vascepa (icosapent ethyl), an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (500 mg/dL) hypertriglyceridemia. Amarin is also developing Vascepa for the treatment of patients with high (TG >=200 mg/dL and <500 mg/dL) triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol, or LDL-C, levels. The company sells Vascepa principally to a limited number of wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, and that in turn resell Vascepa to retail pharmacies for subsequent resale to patients and health care providers. Amarin’s distributors include AmerisourceBergen, Anda Pharmaceuticals, Bellco Drug, Burlington Drug, Capital Wholesale Drug Company, Cardinal Health, Dakota Drug, DIK Drug Company, Frank W. Kerr Company, H.D. Smith Wholesale Drug Company, Kinray, McKesson, Miami Luken and Prescription Supply. The company carries out its research and development (R&D) activities focusing on developing its product portfolio. In FY2016, the company spent US$49.9 million on its R&D activities, which stood at 38.4% of its total revenue. The company’s subsidiaries include: Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Corsicanto and Ester Neurosciences Limited.

Scope of the Report:

About the Company: Historical Details, Current Ownership Structure and basic overview of Balfour Beatty plcin terms of revenue, net income, and operating income.

Financials: Details about Balfour Beatty plclisting status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

Products/Services: Listing of the company’s entire portfolio along with the description of individual products/services providing a clear picture of their target audience.

Company SWOT Analysis: Outlines Atea ASA.’s strengths, weaknesses, and opportunities and threats facing the company.

Recent Developments: Showcases Atea ASA.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

Strategic Evaluation: This section provides an overview of Atea ASA.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

Technology Landscape: Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken by the company at present along with outlook.

Key Questions Answered

What domain does Balfour Beatty plcoperate and what are key points about it?

What is the product/service portfolio of Atea ASA.?

How has Balfour Beatty plcperformed financially from 2013?

How does Balfour Beatty plcrank among its peers in terms of revenue and market share?

What are Balfour Beatty plcstrengths and weaknesses and what opportunities and threats do it face?

What are Atea ASA.’s main growth strategies and how successful has the company been at implementing them?

What is the in-house technical capability of Atea ASA.? Where does it procure/outsource it?

Reasons to buy

Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at a very competitive cost

12 hour delivery time fulfilling your urgent requests as per your requirement

On-demand customization options that can completely cater to your needs by focusing the report on given specifics

For More Information, Get Sample of the report:Request Sample

Got Some Questions? Inquire Here:Inquire Before Buying

Get This Report:Purchase Now

For More Details, Contact Provider Directly:

Kevin Stewart
Sales Manager
Research Cosmos
+1 888 709 8757

Be the first to comment

Leave a Reply